IPN
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Ipsen announced late-breaking IQIRVO data showing that more than 85% of patients on treatment achieved ALP normalization, raising ambitions in primary biliary cholangitis.Nov 9, 2026
- Ipsen Pharma announced late-breaking IQIRVO data showing that more than 85% of patients on treatment achieved ALP normalization, raising ambitions in primary biliary cholangitis.Nov 5, 2026